Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
Analysis of granulosa cells from participants with age-related or pathological ovarian aging identified a crucial factor — NCOA7 — that promotes stress granule clearance via autophagy (‘granulophagy’) ...